Joshua Tolkien Kantrowitz MD
Associate Professor of Clinical Psychiatry at Columbia University
Join to view full profile
1051 Riverside DriveNew York State Psychiatric InstituteNew York, NY 10032
Phone+1 646-774-6738
Dr. Kantrowitz is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterResidency, Psychiatry, 2003 - 2007
State University of New York Downstate Medical Center College of MedicineClass of 2003
Certifications & Licensure
NY State Medical License 2007 - 2028
CT State Medical License 2005 - 2007
American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
Publications & Presentations
PubMed
- Serotonin type 3 receptor (5-HTR) antagonists for negative symptoms and cognitive impairment associated with schizophrenia: a systematic review and meta-analysis.Megan R Mayer, Tse-Hwei Choo, Daniel C Javitt, Joshua T Kantrowitz
Neuropsychopharmacology. 2026-09-01 - A phase 2 randomized controlled trial of luvadaxistat in treatment of adults with cognitive impairment associated with schizophrenia: results from the ERUDITE study.Ni A Khin, Reuben H Fan, Tingting Ge, Hans S Klein, Jacob S Ballon
Neuropsychopharmacology. 2026-04-24 - 4 citationsEffect Size Deflation With Increasing Sample Size in Adjunctive Trials for Negative Symptoms in Schizophrenia: A Meta-Analysis and Meta-Regression Across Mechanisms of...Joshua T Kantrowitz, Megan R Mayer, Tse-Hwei Choo, Kevin Liu, Viraj Govani
The American Journal of Psychiatry. 2026-03-01
Journal Articles
- A Multicenter Study of Ketamine Effects on Functional Connectivity: Large Scale Network Relationships, Hubs and Symptom MechanismsRagy R Girgis, Richard J Maddock, John D Ragland, Daniel C Javitt, Cameron S Carter, Joshua T Kantrowitz, Jeffrey Lieberman, John H Krystal, Lawrence S Kegeles, Willia..., ScienceDirect
Press Mentions
Treatment of Tardive DyskinesiaAugust 13th, 2024- Karuna’s Experimental Schizophrenia Drug Succeeds in Advanced StudyAugust 8th, 2022
Some Caplyta Results in Schizophrenia Reach PrintJanuary 7th, 2020
Grant Support
- Decoded fMRI neurofeedback for auditory verbal hallucinations in schizophreniaCOLUMBIA UNIVERSITY HEALTH SCIENCES2026–2028
- Glutamatergic mechanisms of psychosis and target engagementNEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC2020–2027
- D-serine augmentation of neuroplasticity-based auditory learning in schizophreniaNEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC2019–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
